BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 6217639)

  • 1. [Analysis of lytic effect on fibrin of immobilized heparin in complex with plasma proteins].
    Platé NA; Valuev LI; Gumirova FKh; Maklakova IA
    Vopr Med Khim; 1982; 28(5):19-23. PubMed ID: 6217639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the interaction of heparin-containing polymers with plasma proteins and blood.
    Platé NA; Valuev LI
    Thromb Res; 1982 Jul; 27(2):131-41. PubMed ID: 7135350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low-molecular heparin complex formation with the blood coagulation proteins--thrombin and fibrinogen].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1992; (5):802-6. PubMed ID: 1332992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electron microscopic study of the products from dissolving unstabilized fibrin with complex heparin compounds].
    Ul'ianov AM; Zhitnikova ES
    Biokhimiia; 1978; 43(4):646-52. PubMed ID: 656495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of the fibrinogen-heparin complex in the fibrinolytic activity of the blood euglobulin fraction after the intravenous administration of thrombin or plasmin].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Vopr Med Khim; 1978; 24(2):255-60. PubMed ID: 149422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of nonenzymatic fibrinolysis].
    Litvinov VI; Slabnov IuD; Zubairov DM
    Vopr Med Khim; 1981; 27(4):478-81. PubMed ID: 6457444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
    Pastorova VE
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmin formation in a fibrin network].
    Kotschy M; Knapik M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):167-73. PubMed ID: 4106005
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reaction between blood and heparin immobilized on synthetic polymers].
    Platé NA; Valuev LI
    Biull Eksp Biol Med; 1981 Dec; 92(12):686-8. PubMed ID: 6459806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal fibrin-formation and its inhibition in CAPD.
    Gries E; Paar D; Graben N; Bock KD
    Clin Nephrol; 1986 Oct; 26(4):209-12. PubMed ID: 3780071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the stability of the intermediate fibrin polymers formed in a fibrinogen-thrombin system].
    Ugarova TP; Lugovskoĭ EV; Gorkun OV; Derzskaia SG
    Ukr Biokhim Zh (1978); 1983; 55(3):254-9. PubMed ID: 6868148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Presence of an active fibrinogen--heparin complex in the total blood plasma fraction of plasma fibrinogen degradation products].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Biokhimiia; 1977 Mar; 42(3):451-9. PubMed ID: 861306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinolytic activity in cantharide blisters of urticaria patients].
    Hadlich J
    Hautarzt; 1968 May; 19(5):203-6. PubMed ID: 4235008
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma protein binding properties to immobilized heparin and heparin-albumin conjugate.
    Mirow N; Zimmermann B; Maleszka A; Knobl H; Tenderich G; Koerfer R; Herberg FW
    Artif Organs; 2007 Jun; 31(6):466-71. PubMed ID: 17537059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to reduce hemostatic activation during cardiopulmonary bypass.
    Eisses MJ; Velan T; Aldea GS; Chandler WL
    Thromb Res; 2006; 117(6):689-703. PubMed ID: 15996721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new quick and sensitive method for analysis of fibrin metabolism products in serum--theoretic and practical meaning].
    Gormsen J
    Nord Med; 1970 Jul; 84(31):999. PubMed ID: 4247659
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
    J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
    [No Abstract]   [Full Text] [Related]  

  • 20. Formation of complexes of heparin with proteins and its physiological role. II.
    Lyapina LA; Ul'yanov AM
    Hum Physiol; 1979; 4(2):239-48. PubMed ID: 156146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.